drugset / Trial / NCT01982760

DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty

NCT01982760

Phase 2 Terminated 14 enrolled University Hospitals Cleveland Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

This is study looking at the use of a medication, Desmopressin acetate (DDAVP), to reduce bleeding, swelling, and bruising in patients undergoing cosmetic nose surgery. DDAVP is a drug used in patients with bleeding disorders. It works by activating molecules in the blood stream called platelets that promote clotting. In the study, participants who are have cosmetic nose surgery (rhinoplasty) will be randomly assigned to receive or not receive medication. Photographs taken before and shortly after surgery will be evaluated for the amount of bruising and swelling. Patients with heart, lung, kidney, or liver problems are not eligible to participate.

Timeline

Start
2013-12
Primary completion
2015-06-25
Completion
2015-06-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Desmopressin Peptide 0.3 ug/kg Intravenous

Indications

No indication recorded.